These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8061892)

  • 21. Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia.
    Zitzelsberger H; Bauchinger M; Wilmanns W; Strauss PG
    Cancer Genet Cytogenet; 1990 Jul; 47(2):219-25. PubMed ID: 2357696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemiluminescent detection of DNA on nylon membranes.
    Dubitsky A; Brown J; Brandwein H
    Biotechniques; 1992 Sep; 13(3):392-400. PubMed ID: 1327008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia.
    Hagemeijer A; Buijs A; Smit E; Janssen B; Creemers GJ; Van der Plas D; Grosveld G
    Genes Chromosomes Cancer; 1993 Dec; 8(4):237-45. PubMed ID: 7512367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A complex translocation t(5;9;22) in Philadelphia cells involving the short arm of chromosome 5 in a case of chronic myelogenous leukemia.
    Al-Achkar W; Wafa A; Nweder MS
    J Exp Clin Cancer Res; 2007 Sep; 26(3):411-5. PubMed ID: 17987804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybridization of digoxigenin-labeled probes to Southern blots and detection by chemiluminescence.
    McCreery T; Helentjaris T
    Methods Mol Biol; 1994; 28():107-12. PubMed ID: 8118500
    [No Abstract]   [Full Text] [Related]  

  • 28. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible association of a new translocation, t(7;11)(p15;p15), with Ph1 chromosome-negative chronic myelogenous leukemia.
    Kaneko Y; Maseki N; Takasaki N; Sakurai M; Kawai K; Sakurai M
    Int J Cancer; 1985 Dec; 36(6):657-9. PubMed ID: 3864754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
    Bartram CR
    Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant forms of Philadelphia translocation in two patients with chronic myeloid leukemia.
    Valent A; Zámecníková A; Karlic H; Nowotny H; Krizan P
    Neoplasma; 1996; 43(4):239-44. PubMed ID: 8931748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.
    Shtalrid M; Talpaz M; Blick M; Romero P; Kantarjian H; Taylor K; Trujillo J; Schachner J; Gutterman JU; Kurzrock R
    J Clin Oncol; 1988 Oct; 6(10):1569-75. PubMed ID: 3171624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of strand-specific RNA probes visualized by colorimetric and chemiluminescent reactions for the detection of B19 parvovirus DNA.
    Zerbini M; Musiani M; Gibellini D; Gentilomi G; Venturoli S; Gallinella G; La Placa M
    J Virol Methods; 1993 Dec; 45(2):169-78. PubMed ID: 8113343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transposition of breakpoint cluster region (3' bcr) in CML cells with variant Philadelphia translocations.
    Ohyashiki K; Ohyashiki JH; Kinniburgh AJ; Rowe J; Miller KB; Raza A; Preisler HD; Sandberg AA
    Cancer Genet Cytogenet; 1987 May; 26(1):105-15. PubMed ID: 3030534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of masked and variant Ph (complex type) translocations in CML and classic Ph in AML and ALL by fluorescence in situ hybridization with the use of bcr/abl cosmid probes.
    Chen Z; Morgan R; Berger CS; Pearce-Birge L; Stone JF; Sandberg AA
    Cancer Genet Cytogenet; 1993 Oct; 70(2):103-7. PubMed ID: 8242587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential thrombocythemia with the Philadelphia chromosome and BCR-ABL gene rearrangement. An entity distinct from chronic myeloid leukemia and Philadelphia chromosome-negative essential thrombocythemia.
    LeBrun DP; Pinkerton PH; Sheridan BL; Chen-Lai J; Dubé ID; Poldre PA
    Cancer Genet Cytogenet; 1991 Jul; 54(1):21-5. PubMed ID: 2065312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.